Acetylcholinesterase staining for the pathological diagnosis of Hirschsprung’s disease

Koichiro Yoshimaru, Yusuke Yanagi, Satoshi Obata, Yoshiaki Takahashi, Keiko Irie, Atsuko Omori, Toshiharu Matsuura, Tomoaki Taguchi

Research output: Contribution to journalReview articlepeer-review

4 Citations (Scopus)


Hirschsprung’s disease (HD) is a congenital disease manifesting various degrees of functional bowel obstruction caused by the absence of enteric ganglion cells, which are usually absent in the colonic segment of the HD patient. Because the aganglionic segment of HD always includes the rectum, pathological diagnosis can be made using a rectal sample. HD should be diagnosed as early as possible because serious complications, such as acute enterocolitis or toxic megacolon, can develop without a definitive diagnosis and appropriate treatment. In the mid-1900s, HD was diagnosed by HE staining of specimens obtained by full-thickness biopsy. Since then, the combination of rectal mucosal biopsy and rubeanic acid-amplificated AChE staining has been brought about by the following milestones: the discovery that the submucosal plexus and the intermuscular plexus had the same level of nerve migration; the findings of research on acetylcholine (ACh) and acetylcholinesterase (AChE) in the intestinal tract; and the establishment of a rubeanic acid amplification method. Consequently, the diagnostic rate of HD improved dramatically in the 1980s. This review outlines the history of diagnostic methods for HD, the roles of ACh and AChE in the intestine, and the method of AChE staining.

Original languageEnglish
Pages (from-to)181-186
Number of pages6
JournalSurgery today
Issue number2
Publication statusPublished - Feb 2021

All Science Journal Classification (ASJC) codes

  • Surgery


Dive into the research topics of 'Acetylcholinesterase staining for the pathological diagnosis of Hirschsprung’s disease'. Together they form a unique fingerprint.

Cite this